p-value

A statistical metric measuring the probability that clinical trial or research results occurred by random chance.

A p-value, or probability value, is a statistical metric used to determine the significance of research results, most notably in clinical trials and scientific studies. It measures the probability that the observed difference in outcomes between a treatment group and a control group occurred purely by random chance, assuming there is no actual difference (the null hypothesis). In the biotechnology and pharmaceutical sectors, investors pay close attention to p-values during clinical trial data releases. A lower p-value indicates stronger evidence that the drug or treatment being tested is genuinely effective, rather than its success being a statistical fluke. Conversely, a high p-value suggests that any positive outcomes could easily have occurred by chance, which often leads to trial failure and regulatory rejection. For most clinical trials, a p-value of 0.05 or less is the standard threshold for statistical significance, representing a 5% or lower probability that the results were accidental. However, investors must be cautious of "p-hacking," where researchers run multiple analyses until they find a favorable p-value, or trials that achieve statistical significance (low p-value) but lack clinical significance (the drug's actual real-world benefit is too small to matter).

In a Phase 3 trial for a new cholesterol drug, patients taking the drug saw their LDL cholesterol drop by an average of 20% compared to those taking a placebo. The researchers calculated a p-value of 0.01. This means there is only a 1% chance (1 out of 100) that a difference this large would occur if the drug actually had no effect, indicating a highly significant trial result.